Classifying Chronic Lower Respiratory Disease Events in Epidemiologic Cohort Studies

Abstract

Rationale: One in 12 adults has chronic obstructive pulmonary disease or asthma. Acute exacerbations of these chronic lower respiratory diseases (CLRDs) are a major cause of morbidity and mortality. Valid approaches to classifying cases and exacerbations in the general population are needed to facilitate prevention research.

Objectives: To assess the feasibility, reproducibility, and performance of a protocol to identify CLRD cases and exacerbations triggering emergency department (ED) visits or hospitalizations in cohorts of patients derived from general populations of adults.

Methods: A protocol was developed to classify CLRD cases and severe exacerbations on the basis of review of medical records. ED and inpatient medical records were ascertained prospectively in the Hispanic Community Health Study/Study of Latinos, and inpatient records were retrospectively identified by administrative codes in the Multi-Ethnic Study of Atherosclerosis. "Probable" exacerbations were defined as a physician's diagnosis of CLRD with acute respiratory symptoms. "Highly probable" exacerbations additionally required systemic corticosteroid therapy, and "definite" exacerbations required airflow limitation or evidence of CLRD on imaging studies. Adjudicated results were compared with CLRD cases identified by spirometry and self-report, and with an administrative definition of exacerbations.

Measurements and main results: Protocol-based classification was completed independently by two physicians for 216 medical records (56 ED visits and 61 hospitalizations in the Hispanic Community Health Study/Study of Latinos; 99 hospitalizations in the Multi-Ethnic Study of Atherosclerosis). Reviewer disagreement occurred in 2-5% of cases and 4-8% of exacerbations. Eighty-nine percent of records were confirmed as at least probable CLRD cases. Fifty-six percent of confirmed CLRD cases had airflow limitation on the basis of baseline study spirometry. Of records that described CLRD as the primary discharge diagnosis code, an acute exacerbation was confirmed as at least probable for 96% and as highly probable or definite for 77%. Only 50% of records with CLRD as a secondary code were confirmed, although such records accounted for over half of all confirmed exacerbations.

Conclusions: CLRD cases and severe exacerbations without preceding documentation of airflow limitation are identified frequently in population-based cohorts of persons. A primary discharge diagnosis of CLRD is specific but insensitive for defining exacerbations. Protocol-based classification of medical records may be appropriate to supplement and to validate identification of CLRD cases and exacerbations in general population studies. Clinical trials registered with www.clinicaltrials.gov (NCT00005487 and NCT02060344).

Keywords: administrative data; asthma; chronic obstructive pulmonary disease; disease progression; incidence.

Figures

Figure 1.

Classification samples for the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) and the Multi-Ethnic Study of Atherosclerosis (MESA), 2000–2013. CLRD = chronic lower respiratory disease; ED = emergency department; ICD = International Classification of Diseases.

Figure 2.

Confirmation of medical records as chronic lower respiratory disease (CLRD) cases and CLRD exacerbations, by cohort. ED = emergency department; HCHS/SOL = Hispanic Community Health Study/Study of Latinos; MESA = Multi-Ethnic Study of Atherosclerosis.

Figure 3.

Confirmation of chronic lower respiratory disease (CLRD) cases and CLRD exacerbations according to selected characteristics in the pooled cohort sample. ICD = International Classification of Diseases.

Figure 4.

Positive predictive value (PPV) and negative predictive value (NPV) of airflow limitation at study baseline and primary International Classification of Diseases (ICD) code position with respect to protocol-defined endpoints, by cohort. CLRD = chronic lower respiratory disease; ED = emergency department; HCHS/SOL = Hispanic Community Health Study/Study of Latinos; MESA = Multi-Ethnic Study of Atherosclerosis.